DNA vaccine could help MS sufferers: study
CTV.ca - Canada
A research team led by Montreal neurologist and neuroimmunologist Dr. Amit Bar-Or tested the effectiveness of the vaccine, called BHT-3009. ...
See all stories on this topic

'DNA Vaccine' For Multiple Sclerosis, UK
Medical News Today Wed, 15 Aug 2007 3:38 AM PDT
Scientists have reported that a newly developed DNA vaccine appears safe and may produce beneficial changes in the brains and immune systems of individuals with multiple sclerosis (MS). [click link for full article]

Three Important Multiple Sclerosis Studies Reported This Week - International Collaboration Identifies New Risk Genes ...
Medical News Today Wed, 15 Aug 2007 2:11 AM PDT
The International Multiple Sclerosis Genetics Consortium (IMSGC) has identified two new genetic variations associated with multiple sclerosis. In addition, two independent collaborating groups are publishing papers in Nature Genetics confirming one of these gene variations. [click link for full article]

DNA Vaccine May Treat Multiple Sclerosis
Slashdot Tue, 14 Aug 2007 10:34 PM PDT
GSASoftware writes "Multiple sclerosis is a serious, as-yet incurable neurological disease which causes blindness, paralysis and other serious symptoms. In a new development, a neuroimmunology researcher in Montreal has developed a therapeutic DNA vaccine. The cause of the disease is not fully understood, but it appears to be auto-immune. If a DNA vaccine can be an effective therapy for this ...

DNA Vaccine Against Multiple Sclerosis Appears Safe, Potentially Beneficial
Science Daily Tue, 14 Aug 2007 11:03 AM PDT
A newly developed DNA vaccine appears safe and may produce beneficial changes in the brains and immune systems of individuals with multiple sclerosis, according to a new article.

Wishart cooks up fundraiser
The Scotsman Wed, 15 Aug 2007 4:54 AM PDT
MICHELIN starred city chef Martin Wishart has produced new recipes to help raise funds for the Multiple Sclerosis Trust.

DNA Vaccine May Offer Hope For MS
CBS News Tue, 14 Aug 2007 1:00 PM PDT
A new kind of vaccine may halt destructive immune responses in multiple sclerosis and could bring hope for sufferers of type 1 diabetes and other autoimmune diseases.

Experimental MS vaccine appears to be safe
ABC 7 Chicago Tue, 14 Aug 2007 2:56 PM PDT
An experimental vaccine against multiple sclerosis appears to be safe and may produce beneficial changes in patients' brains and immune systems.

MS patients given hope with new vaccine treatment
News-Medical-Net Tue, 14 Aug 2007 6:54 PM PDT
Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.

Research finds promising new vaccine for MS
WTNH-TV New Haven Tue, 14 Aug 2007 4:22 PM PDT
(WTNH, Aug. 14, 2007 7:05 PM) _ There's a promising new vaccine which could one day prevent or treat multiple sclerosis.

HIV/AIDS Inhibits Neural Stem Cell Proliferation
Wired News - USA
A protein associated with AIDS prevents neural progenitors (stem cells) from replicating, according to a priority publication in Cancer Stem Cells. ...
See all stories on this topic

Purification patent grant bolsters Stem Cell's stock
The Herald - Glasgow,Scotland,UK
Stem cells are the building blocks of other cells, which researchers believe can be coaxed and grown into any type of cell in the human body. ...
See all stories on this topic

Scientists Help Multiple Sclerosis Patients Without Embryonic Stem ...
LifeNews.com - Helena,MT,USA
... have developed a vaccine that, in early testing, appears to help patients with multiple sclerosis without relying on controversial embryonic stem cells. ...
See all stories on this topic

Pipex Pharmaceuticals' Oral TRIMESTA Initiates Dosing in Phase II ...
PipelineReview.com (press release) - Barcelona,Spain
Pipex Pharmaceuticals, Inc. announced today that it has initiated patient dosing of TRIMESTA (oral estriol), its proprietary therapy for multiple sclerosis ...
See all stories on this topic

MSLeaders.org invites you to view our latest CME program, Diagnosis and Management of Primary Progressive Multiple Sclerosis. This program is presented by The Johns Hopkins University School of Medicine, and offers free 1.0 AMA PRA Category 1 Credit(s)™.

Primary progressive multiple sclerosis (PPMS) affects about 10% of patients with the disease. Clinical data suggests that PPMS is a spectrum of illness, ranging from relapsing-remitting to secondary progressive to primary progressive. Certain clinical features are somewhat more characteristic of PPMS, but it appears to also have quite a bit in common with the other subtypes of the disease. In this program, Drs. Peter Calabresi, Bruce Cree and Michael Racke discuss recent clinical studies, review diagnostic criteria, and describe their own experiences in the diagnosis and management of PPMS.

To view the full CME information and begin watching this informative new program, click here.

Also, while visiting MSLeaders.org, check out the program, MS Highlights of the American Academy of Neurology 2007, which offers up to 1.2 CEU credits or up to 1.0 AMA credits.